XML 43 R31.htm IDEA: XBRL DOCUMENT v3.19.1
Notes Payable (Details Narrative) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2018
May 31, 2018
Feb. 28, 2018
Dec. 09, 2017
Feb. 02, 2016
Jan. 29, 2016
Jun. 25, 2012
Sep. 30, 2018
Dec. 31, 2018
Dec. 31, 2017
Apr. 09, 2018
Apr. 05, 2018
Sep. 23, 2016
Sep. 22, 2016
Dec. 31, 2015
Dec. 31, 2014
Aug. 10, 2012
Debt instrument interest rate                 8.93%                
Debt maturity date             Jun. 25, 2013                    
Interest expense                 $ 136,243 $ 102,225              
Warrant exercise price                 $ 1.50 $ 2.75              
Common stock closing price, per share                       $ 1.12         $ 18.2000
Loss on extinguishment of debt       $ 85,081         $ (105,254)              
Converted into common stock                 16,460                
Stockholder's percentage             20.00%                    
Percentage of convertible notes payable             12.00%                    
Insurance premium                 $ 63,750                
Short term borrowings                 8,907 8,630              
Ten Monthly Installments [Member]                                  
Debt periodic payments                 6,639                
SY Corporation [Member]                                  
Convertible notes payable aggregate amount             $ 400,000                    
Interest expense                 47,973 47,973              
SY Corporation [Member] | Won [Member]                                  
Convertible notes payable aggregate amount             $ 465,000,000                    
Exchange Agreement [Member]                                  
Debt instrument interest rate     10.00%                            
Convertible notes payable aggregate amount   $ 169,715 $ 43,552                            
Number of exchanged for common stock shares   169,715 58,071                            
Common stock exchange rate per share   $ 0.75 $ 0.75                            
Common stock closing price, per share   $ 0.92 $ 1.90                            
Debt instrument default interest rate per year     12.00%                            
Accrued interest   $ 226,287                              
Market value of common stock on exchange   208,185                              
Loss on extinguishment of debt   $ 38,470                              
Premium Financing Arrangement [Member]                                  
Debt periodic payments                 9,322                
Board of Directors [Member] | Exchange Agreement [Member]                                  
Debt instrument interest rate     10.00%                            
Common stock exchange rate per share     $ 0.75                            
Dr. Lippa [Member]                                  
Interest expense                 11,268 7,760              
Percentage of convertible notes payable           10.00%             10.00%        
Advances total           $ 52,600         $ 50,000   $ 25,000        
Issuance of fully vested warrant to purchase shares of common stock           15,464                      
Dr. Lippa [Member] | Tranche One [Member]                                  
Warrant to purchase shares           10,309                      
Warrant exercise price           $ 5.1025                      
Dr. Lippa [Member] | Tranche Two [Member]                                  
Warrant to purchase shares           5,155                      
Warrant exercise price           $ 4.85                      
Dr. Arnold S.Lippa [Member]                                  
Advances total                     50,000            
Warrants expires date description               The warrant expires on January 29, 2019 and September 23, 2019.                  
Dr. James S. Manuso [Member]                                  
Interest expense $ 3,564               $ 12,769 7,760              
Percentage of convertible notes payable         10.00%                        
Advances total         $ 52,600           50,000            
Issuance of fully vested warrant to purchase shares of common stock         13,092                        
Dr. James S. Manuso [Member] | Tranche One [Member]                                  
Warrant to purchase shares         8,092                        
Warrant exercise price         $ 6.50                        
Dr. James S. Manuso [Member] | Tranche Two [Member]                                  
Warrant to purchase shares         5,000                        
Warrant exercise price         $ 5.00                        
Dr. Manuso [Member]                                  
Percentage of convertible notes payable                           10.00%      
Advances total                     50,000     $ 25,000      
Four Officer [Member]                                  
Warrants expires date description                 The warrants expire on February 2, 2019 and September 22, 2019                
Dr. Arnold S. Lippa and Dr. James S. Manuso [Member]                                  
Convertible notes payable aggregate amount                 $ 250,000                
Advances total                     $ 100,000            
Closing value of common stock                 150,000                
2018 Convertible Notes [Member]                                  
Debt instrument original issue discount                 27,968              
Accrued interest                 $ 401              
2018 Convertible Notes [Member] | Investor [Member]                                  
Debt instrument interest rate                 10.00%                
Debt maturity date                 Feb. 28, 2019                
Convertible notes payable aggregate amount                 $ 80,000                
Warrant to purchase shares                 80,000                
Value of warrants to purchase shares                 $ 148,025                
Debt instrument original issue discount                 36,347                
Initial value of note                 43,653                
Interest expense                 8,379                
Addtional debt interest expense                 $ 401                
Warrant exercise price                 $ 1.50                
2018 Convertible Notes [Member] | Investor [Member] | Black Scholes Option Pricing Model [Member]                                  
Value of warrants to purchase shares                 $ 68,025                
Convertible Notes Payable [Member]                                  
Debt instrument interest rate                 10.00%                
Warrant to purchase shares                 27,936                
Warrant exercise price                 $ 11.375                
Extended maturity date                 Sep. 15, 2016                
Convertible Notes Payable [Member] | Minimum [Member] | October 3, 2016 and October 25, 2016                                  
Debt instrument interest rate                 10.00%                
Convertible Notes Payable [Member] | Maximum [Member] | October 3, 2016 and October 25, 2016                                  
Debt instrument interest rate                 12.00%                
Convertible Notes Payable [Member] | Investor [Member]                                  
Debt instrument interest rate                             10.00% 10.00%  
Convertible notes payable aggregate amount                             $ 579,500 $ 579,500  
Warrant to purchase shares                             50,945 50,945  
Shares issued price per share                             $ 11.3750 $ 11.3750  
Warrants exercisable fixed price per share                             $ 11.3750 $ 11.3750  
Two Convertible Notes [Member]                                  
Debt periodic payments     $ 66,782                            
Convertible Notes [Member]                                  
Debt periodic payments                 $ 38,292 91,028              
Accrued interest                 13,292 25,028              
Original Convertible Notes [Member]                                  
Accrued interest                 $ 62,233 $ 98,646              
Converted into common stock                 16,460 32,941              
Number of conversion into common shares attributable to accrued interest                 5,471 8,677